OOIR: Observatory of International Research

Papers

(The H4-Index of Cardiovascular Research is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Corrigendum to: Scientist on the spot: Exploring the cause and cure for pulmonary arterial hypertension	1088
Scientist on the Spot: Exploring the cause and cure for pulmonary arterial hypertension	237
Correction to: Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling	147
Timing of capillary enlargement after adenoviral VEGF gene transfer does not support post-ischemic skeletal muscle recovery in hyperlipidemic mice	133
Murine matrix metalloproteinase 13 and human matrix metalloproteinase 1 are involved in remodelling processes after myocardial infarction	133
Cardioprotective effects of Empagliflozin in cardiac volume overload-induced by aortocaval fistula in rats	133
In vivo calcium and voltage mapping of the zebrafish heart	123
Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter?	113
Caveolin-dependent endocytosis regulates arterial calcification	104
The endocannabinoid ARA-S acts as an endogenous rescuing factor of Kv7.1/KCNE1 carrying Long QT syndrome mutations and paves the way for drug development strategies	92
The mechanistic role of connexin 43 in maturation of hiPSC cardiomyocytes	90
The role of natural anti-oxidants in gut microbiota alteration subsequent to high fat diet (HFD)	81
Role of NOD1 in atrial myopathy associated with heart failure	79
Stage specific effects of insulin and Wnt on cell fate decisions in human induced pluripotent stem cell-derived cardiomyocytes	77
From genes to phenotype: investigating the link between smad2rs29725537:c>a and high take off in mice	76
Transcriptional regulation of macrophage inflammation in the heart failure with preserved ejection fraction	75
FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction	73
Impaired autophagy mechanisms associated with phospholamban-R14del disease	72
The role of FGL2 in vascular smooth muscle cell dysfunction in coronary artery bypass vein graft failure	71
Single-cell RNA sequencing analysis of the human fetal epicardium reveals several new genes involved in regulation of epicardial activation	70
Lenti-viral overexpression of RhoGEF Trio reduces CD8 T cell extravasation into atherosclerotic vein graft lesions in mice	67
Mechanisms of vascular inflammaging: TNF-alpha mediates endothelial CEACAM1 expression by NF-KB and beta-Catenin in a biphasic manner	65
Deficiency of Abca1 and Abcg1 mediated cholesterol efflux pathways in smooth muscle cells enhances vasoconstriction but does not affect atherosclerosis	65
Differential preoperative transcriptomic profiles are related to the quality of left ventricle reverse remodelling one year after valve replacement in patients with severe aortic valve stenosis	64
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis	64

Rapamycin reduces atherosclerotic plaque inflammation in aged mice	63
Cardiovascular toxicity profile of doxorubicin: data mining of the FDA adverse event reporting system (FAERS)	63
Asporin expression is associated with human atherosclerotic plaque integrity	62
Circulating cluster miR-99b/let-7e/miR-125a expression associates with endothelial function, cytokine, and chemokine levels in myocardial infarction patients	61
Inflammasome activation dynamics within the first 24 hours in patients treated with PCI for myocardial infarction is influenced by the age of patients, preliminary report	61
The aging of neutrophils is actively involved in the cardio-metabolic consequences of high fat diet	60
Drug-interacting gene expression levels differ between atherosclerotic plaque subtypes	59
Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound	55
Short- and long term preservation of cardiac tissue-engineered constructs	54
Modulating sialylation as therapeutic approach for preventing age-associated cardiac dysfunction	53
Elderberry extract inhibits tumour necrosis factor induced monocyte adhesion to endothelial cells via modulation of the NF-κB pathway	52
Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes	52
Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells	49
Tenascin-C provokes cardiac fibrosis and endothelial impairment in Duchenne Muscular Dystrophy	48
Corrigendum to: Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines	47
Finding the culprit for the failure of the immune clock as time goes by	47
Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device	46
Therapeutic targeting of cell transition: ready for clinical prime-time?	46
Epicardium-derived extracellular vesicles: a promising avenue for cardiac regeneration	46
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence	45
Dissecting the transcriptome in cardiovascular disease	45